Re: Minocycline-induced autoimmune hepatitis with subsequent cirrhosis [1]

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 3, 2007, Pages 389-

  Basude, D ^a   Dhawan, A ^b  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CASE REPORT; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CHRONOLOGY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; HYPERSPLENISM; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; PETECHIA; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; THROMBOCYTOPENIA; NOTE; TOXIC HEPATITIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; HEPATITIS, AUTOIMMUNE; HEPATITIS, TOXIC; HUMANS; MINOCYCLINE;

EID: 33847711378     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31802eecf3     Document Type: Letter

References (4)

1. Chamberlain MC, Schwarzenberg SJ, et al. Minocycline-induced autoimmune hepatitis with subsequent cirrhosis. J Pediatr Gastroenterol Nutr 2006;42:232-5.
2. Maria VAJ, Victorino RMM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997;26:666-9.
3. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-97.
4. Gough A, Chapman S, Wagstaff K, et al. Minocycline-induced autoimmune hepatitis and systemic lupus erythromatosis-like syndrome. BMJ 1996;312:369-72.